Education
About Us
Working with TipRanks
Follow Us
Phio Pharmaceuticals (PHIO)
NASDAQ:PHIO
Total Valuation
Phio Pharmaceuticals has a market cap or net worth of $11.51M. The enterprise value is $492.91K.
Market Cap$11.51M
Enterprise Value$492.91K
Share Statistics
Phio Pharmaceuticals has 5,726,750 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,726,750
Owned by Insiders1.13%
Owned by Institutions0.25%
Financial Efficiency
Phio Pharmaceuticals’s return on equity (ROE) is -1.51 and return on invested capital (ROIC) is -156.40%.
Return on Equity (ROE)-1.51
Return on Assets (ROA)-1.25
Return on Invested Capital (ROIC)-156.40%
Return on Capital Employed (ROCE)-1.56
Revenue Per Employee0.00
Profits Per Employee-1.43M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Phio Pharmaceuticals is ―. Phio Pharmaceuticals’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value3.00
Price to FCF―
Price to Operating Cash Flow>-0.01
PEG Ratio―
Income Statement
In the last 12 months, Phio Pharmaceuticals had revenue of 0.00 and earned -7.15M in profits. Earnings per share was -0.91.
Revenue0.00
Gross Profit-35.00K
Operating Income-7.39M
Pretax Income-7.15M
Net Income-7.15M
EBITDA-7.12M
Earnings Per Share (EPS)-0.91
Cash Flow
In the last 12 months, operating cash flow was -6.55M and capital expenditures -6.00K, giving a free cash flow of -6.55M billion.
Operating Cash Flow-6.55M
Free Cash Flow-6.55M
Free Cash Flow per Share-1.14
Dividends & Yields
Phio Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.35
52-Week Price Change-35.69%
50-Day Moving Average2.34
200-Day Moving Average2.14
Relative Strength Index (RSI)39.36
Average Volume (3m)1.83M
Important Dates
Phio Pharmaceuticals upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
Phio Pharmaceuticals as a current ratio of 5.65, with Debt / Equity ratio of 0.00%
Current Ratio5.65
Quick Ratio5.65
Debt to Market Cap0.00
Net Debt to EBITDA0.76
Interest Coverage Ratio-31.98
Taxes
In the past 12 months, Phio Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Phio Pharmaceuticals EV to EBITDA ratio is -1.24, with an EV/FCF ratio of -1.24.
EV to Sales0.00
EV to EBITDA-1.24
EV to Free Cash Flow-1.24
EV to Operating Cash Flow-1.24
Balance Sheet
Phio Pharmaceuticals has $10.78M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$10.78M billion.
Cash & Marketable Securities$10.78M
Total Debt$0.00
Net Cash-$10.78M
Net Cash Per Share-$1.88
Tangible Book Value Per Share$0.60
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Phio Pharmaceuticals is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$14.00
Price Target Upside569.86% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast85.26%